SCHEMBL25933337

SCHEMBL25933337

C=CC(=O)OC(CCCCC)NC

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.46
HPGD P15428 1/20 0.46
THRB P10828 2/20 0.40
ZDHHC20 Q5W0Z9 1/20 0.40
ZDHHC2 Q9UIJ5 1/20 0.40
ZDHHC7 Q9NXF8 1/20 0.39
ABCB1 P08183 1/20 0.37
FAAH O00519 4/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
THRA P10827 1/20 0.36
ALDH1A1 P00352 1/20 0.35
GPR84 Q9NQS5 3/20 0.35
FFAR1 O14842 1/20 0.35
CA1 P00915 1/20 0.35
PLA2G2C Q5R387 1/20 0.35
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28852509 0.97 TSHR (0.43) TSHRHPGDTHRBZDHHC20ZDHHC2
SCHEMBL5504190 0.87 TSHR (0.41) TSHRHPGDTHRBZDHHC20ZDHHC2
SCHEMBL10382473 0.87 TSHR (0.43) TSHRHPGDTHRBZDHHC20ZDHHC2
SCHEMBL11310728 0.84 TSHR (0.41) TSHRHPGDTHRBZDHHC20ZDHHC2
SCHEMBL515831 0.82 TSHR (0.39) TSHRHPGDTHRBALDH1A1
SCHEMBL25933341 0.81 ZDHHC7 (0.38) ZDHHC20ZDHHC2ZDHHC7ABCB1FAAH
SCHEMBL769930 0.81 TSHR (0.47) TSHRHPGDTHRBZDHHC20ZDHHC2
SCHEMBL31742398 0.80 TSHR (0.50) TSHRHPGDTHRBZDHHC20ZDHHC2
Hydrochloric Acid SCHEMBL28283677 0.80 TSHR (0.38) TSHRHPGDTHRBALDH1A1
SCHEMBL160397 0.80 TSHR (0.50) TSHRHPGDTHRBZDHHC20ZDHHC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242548-A1 COMPOSITIONS AND METHODS FOR TREATING CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242548-A1 COMPOSITIONS AND METHODS FOR TREATING CANCER KRAS, HRAS, NRAS TSHR 4752/4885HPGD 1795/4885THRB 3669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.